A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults
Clinical trial NCT04224701 · COMPLETED
Trial details
- NCT number
- NCT04224701
- Sponsor
- International AIDS Vaccine Initiative
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2023-07-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.